What are the early signs of rheumatoid arthritis?

Key early signs include: symmetrical small joint pain or swelling (both wrists, both knuckles, both ankles), morning stiffness lasting more than 30 minutes that improves as you move, persistent fatigue that doesn't improve with rest, and warmth or swelling in affected joints. RA is different from osteoarthritis — it often affects both sides of the body simultaneously and tends to involve smaller joints first. If these symptoms persist beyond several weeks, ask your GP about rheumatoid factor and anti-CCP antibody blood tests.

Yes. Disease-modifying antirheumatic drugs (DMARDs) are the first-line treatment and are effective for many people. For those who do not respond to standard DMARDs, biologic therapies targeting specific immune pathways have transformed outcomes over the past two decades. Early treatment — ideally within the first three to six months of onset — significantly reduces joint damage and long-term disability. A rheumatologist manages ongoing care; your GP is the starting point for investigation and referral.

Usman Khawaja's 17-year RA: what autoimmune arthritis actually looks like

On Sunday, Usman Khawaja — 88 Tests, over a decade as one of Australia’s most gifted batters — revealed that he played his entire career while living with rheumatoid arthritis. He was diagnosed at 22, during an off-season. Before the diagnosis, the pain in his left knee was so severe he couldn’t walk ten metres to the bathroom. He told the ABC he genuinely thought he was dying.

He told coaching staff and medical teams. He told nobody else in the Australian dressing room for the remainder of his career.

The story is being told as one about resilience — and that framing is fair. But there is a clinical layer underneath it worth unpacking, particularly for the roughly 400,000 Australians — most of them women — who are living with RA right now.

What rheumatoid arthritis actually is

Rheumatoid arthritis is an autoimmune condition. The immune system attacks the synovial membrane — the thin tissue that lines the spaces inside joints and keeps them lubricated. The result is inflammation that causes pain, swelling, warmth, and stiffness. Over time, untreated or undertreated RA can damage cartilage and bone within the affected joints.

About 2% of Australians have rheumatoid arthritis. Women are approximately three times more likely to develop it than men. Peak onset in women is between the ages of 30 and 60, with a notable rise in the years around perimenopause.

It is not the same disease as osteoarthritis. Osteoarthritis is the gradual wear-and-tear of joint cartilage, most common in hips and knees, associated with ageing and load. Rheumatoid arthritis is an immune-mediated condition that tends to affect the small joints of hands, wrists, and feet first, often symmetrically — both hands together, both ankles together — and comes with systemic features like fatigue and malaise that osteoarthritis does not. Calling both “arthritis” in conversation collapses a distinction that matters for treatment.

The part that doesn’t get told

Khawaja kept his diagnosis quiet partly because he didn’t want special treatment — and partly because he feared the label would be used against him in a sport where he already knew his selection was contested.

That calculation is familiar in workplaces and sporting environments. It also has a direct parallel in clinical settings, where the experience of being believed matters as much as the test result.

People with RA — particularly women — wait an average of two to five years between first symptoms and a confirmed diagnosis. The reasons are layered. Symptoms fluctuate: good days and bad days make the picture inconsistent from one consultation to the next. Early blood tests can be normal: rheumatoid factor and anti-CCP antibodies may be negative in early seropositive disease, and seronegative RA — where they remain negative throughout — is also common. And joint pain in women, particularly fatigue-associated joint pain, is disproportionately attributed to stress, lifestyle, or vague explanations before autoimmune investigation is considered.

Khawaja describes being unable to walk, fearing he was dying, before a diagnosis was made. That experience — severe symptoms, delay, then an unlocking diagnosis — is not unique to elite athletes.

Modern treatment has changed the picture

The drug Khawaja calls a “godsend” is not named in the ABC story. Given the timeline of his diagnosis (mid-2000s onwards) and the description of a regular injection that returned him to cricket within about six months, it is consistent with a biologic therapy — a class of medications that target specific immune pathways driving RA inflammation.

Biologic therapies have genuinely transformed outcomes for people with rheumatoid arthritis. For patients who respond, the change can be profound: sustained reduction in joint pain and swelling, preservation of function over time, the ability to work, exercise, and live fully. This is not aspirational language — it is what the clinical evidence demonstrates.

The distinction that matters here is between treatment and diagnosis. The treatment Khawaja found works. The issue is the time it takes — for many people with RA — to reach the point where that treatment is offered.

Early disease-modifying therapy, started within the first three to six months of symptom onset, significantly reduces joint damage and long-term disability compared with delayed treatment. The window for preventing irreversible structural damage is real, and it closes. Silence in that window has long-term consequences.

Both-and: what the Khawaja story does and doesn’t model

Khawaja’s narrative can reasonably be read as inspiring. A career-defining autoimmune diagnosis in early adulthood, managed through modern medicine, enabled peak athletic performance for nearly two decades. That is true.

It can also be read as a template — if he managed it quietly, perhaps I should keep quiet too and just push through. That reading carries risk. Khawaja had rapid access to expert diagnosis and treatment through cricket’s medical support infrastructure. He had the physiological reserve of a professional athlete in his early twenties. Most people with RA do not have those advantages.

The lesson worth taking from his story is not about silence or stoicism. It is that rheumatoid arthritis, when diagnosed and treated promptly, does not have to define the ceiling of what someone can do.

2 cents: what to look for

If you have persistent joint symptoms that fit any of these descriptions:

Symmetrical small joint pain or swelling — both wrists, both knuckles, both ankles
Morning stiffness lasting more than 30 minutes that eases as you move
Fatigue alongside joint symptoms that doesn’t resolve with rest
Warmth or visible swelling in affected joints

…ask your GP to order a rheumatoid factor and anti-CCP antibody blood test at your next appointment. These are standard blood tests, not specialist referrals. They won’t catch every case — early and seronegative RA can present with normal results — but they are the right starting point and they change the clinical conversation.

If those tests are normal but symptoms persist, the next step is a referral to a rheumatologist. Waiting to see if things resolve on their own is the single most common reason for delayed RA diagnosis. The condition does not reliably resolve on its own.

Khawaja’s story is, at its core, about what becomes possible when the right diagnosis is made. That part applies to everyone.

Verdict: yes — worth knowing about.